| 发明名称 |
BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF |
| 摘要 |
The application discloses Quiescin Q6 as a new biomarker for acute heart failure. Methods for determining the quantity of Quiescin Q6 in a sample from a subject are described. The quantity of Quiescin Q6 is determined by contacting the sample with one or more binding agents capable of specifically binding to Quiescin Q6. |
| 申请公布号 |
US2017010265(A1) |
申请公布日期 |
2017.01.12 |
| 申请号 |
US201615242044 |
申请日期 |
2016.08.19 |
| 申请人 |
MyCartis NV |
发明人 |
Kas Koen |
| 分类号 |
G01N33/573 |
主分类号 |
G01N33/573 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for determining the quantity of Quiescin Q6 in a sample from the subject, the method comprising the steps:
(i) obtaining a sample from the subject; and (ii) determining the quantity of Quiescin Q6 by contacting the sample with one or more binding agents capable of specifically binding to Quiescin Q6. |
| 地址 |
Gent BE |
